Wan Chieh (Jenny) Lee is a partner in the New York office of Haug Partners. Her practice focuses on strategic counseling, procurement of worldwide patent rights, due diligence, freedom to operate, and intellectual property transactions. She routinely advises clients in the pharmaceutical, biotechnology and medical device industries regarding patentability, validity, freedom-to-operate, and regulatory exclusivity. Drawing from her extensive experience across all aspects of patent practice, Ms. Lee develops and executes patent procurement strategies that are aligned with clients’ immediate and long-term business goals, including product life cycle management under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. She leverages her strong ability to digest complex technical information with her experience in both patent procurement and litigation to provide clients with valuable transactional insights and a unique approach to negotiating intellectual property terms in agreements.
Ms. Lee’s experience spans a broad range of life science technologies including antibodies, vaccines, small molecule pharmaceuticals, diagnostics, veterinary formulations, data science, biomaterials and medical devices. She also has experience with a variety of other technologies including polymers, cosmetics, industrial chemicals, manufacturing process controls, paper, and software.
During her time at MIT, Ms. Lee participated in cardiac and cartilage tissue engineering research using polymeric scaffolds, for which she earned the school’s bioengineering undergraduate research award. Additionally, she researched and studied drug delivery coatings for cardiovascular stents, and served as a teaching assistant for the undergraduate polymer chemistry laboratory. Ms. Lee also worked at a major pharmaceutical company where she designed and conducted experiments related to pharmaceutical manufacturing.